4/A//SEC Filing
OXIGENE INC 4/A
Accession 0001209191-16-114834
$OTLCCIK 0000908259operating
Filed
Apr 18, 8:00 PM ET
Accepted
Apr 19, 4:05 PM ET
Size
6.2 KB
Accession
0001209191-16-114834
Insider Transaction Report
Form 4/AAmended
OXIGENE INCOXGN
Schwieterman William D
Director
Transactions
- Award
Employee Stock Option (Right to Buy)
2016-03-21+500,000→ 500,000 totalExercise: $0.73Exp: 2026-03-21→ Common Stock (500,000 underlying)
Footnotes (2)
- [F1]Dr. Schwieterman was awarded options to purchase OXiGENE, Inc. common stock, $0.01 par value per share (the "Stock Options"), pursuant to the OXiGENE, Inc. 2015 Equity Incentive Plan in connection with his service as President and Chief Executive Officer. The original Form 4 filed on March 23, 2016 (the "Original Form 4") is amended by this Form 4 amendment to correctly reflect the number of Stock Options granted and the number of derivative securities beneficially owned following the reported transaction. No other changes have been made to the Original Form 4.
- [F2]25% of the Stock Options will vest on the first anniversary of the date of grant, and the remainder will vest in 36 substantially equal monthly installments beginning one year and one month after the grant date.
Documents
Issuer
OXIGENE INC
CIK 0000908259
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000908259
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 18, 8:00 PM ET
- Accepted
- Apr 19, 4:05 PM ET
- Size
- 6.2 KB